Global Overactive Bladder Therapeutics Market 2014-2018

Topics: Adrenergic receptor, Medicine, Urology Pages: 2 (377 words) Published: November 3, 2014

Global Overactive Bladder Therapeutics Market 2014-20180280035Overactive bladder (or overactive bladder syndrome) is a urological condition characterized by storage symptoms such as urgency, changes in the frequency of urination, nocturia, or incontinence. Although not a life-threatening condition, it is often debilitating and stigmatized. The pathophysiology of overactive bladder is not characterized completely. The symptoms can be lifelong or relapsing and remitting or it can be resolved. An overactive bladder can affect anyone irrespective of their gender. It is caused by the abnormal contraction of the detrusor muscles of the bladder. An overactive bladder can also be related to neurological diseases such as Parkinson's disease and multiple sclerosis.  

Covered in this Report0280035This report covers the present scenario and the growth prospects of the Global Overactive Bladder Therapeutics market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various branded, generic, and off-label drugs used to treat overactive bladder, which include: Antimuscarinic agents

Beta-3 adrenergic receptor agonists
View our full TOC hereKey Regions
EMEA
APAC
Americas
Key Vendors
Actavis plc.
Allergan Inc.
Astellas Pharma Inc.
Pfizer Inc.
Other Prominent Vendors
Addex Therapeutics
AltheRx Pharmaceuticals
American Oriental Bioengineering
Antares Pharma
Apogepha Arzneimittel
Auxilium Pharmaceuticals
Bayer
ElbionFemmePharma
Ferring Pharmaceuticals
GlaxoSmithKline
Hisamitsu Pharmaceutical
Hydra Biosciences
Ion Channel Innovations
IpsenJanssen
Kissei Pharma
Kwang Dong Pharmaceutical
KYORIN Pharma
Laboratorios SALVAT
LG Life Sciences
Lipella Pharmaceuticals
Merck
Motif BioSciencesMylanNovartis
Ono Pharmaceuticals
Ranbaxy Laboratories
RecordatiSanofi
SunovionTakeda Pharmaceutical
Taris BioMedicalTeva Pharmaceutical
TheraVidaToray Industries
Urigen Pharmaceuticals
Key...
Continue Reading

Please join StudyMode to read the full document

You May Also Find These Documents Helpful

  • Global Peptide Therapeutics Market 2014-2018 Essay
  • Global Furniture Market 2014-2018 Essay
  • Global PLC Market 2014-2018 Essay
  • Global Cheese Market 2014-2018 Essay
  • Essay about Global PGD Market 2014-2018
  • Global EDA Market 2014-2018 Essay
  • Essay on The Global BPO Market 2014-2018
  • Global VoLTE Market 2014-2018 Essay

Become a StudyMode Member

Sign Up - It's Free